Corporate Action- Record Date for dividend Purpose: September 04, 2026

July 29, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM Subject: Intimation of Annual General Meeting and Record date Dear Sir/ Madam, This is to inform you that the 47th Annual General Meeting (the ‘AGM’) of the Members of the Company will be held on Friday, September 18, 2026 at 03:30 p.m. (IST) through Video Conferencing (‘VC’)/Other Audio Visual Means (‘OAVM’) in compliance with the applicable circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (‘SEBI’). As intimated earlier, Board of Directors of the Company at their meeting held on April 27, 2026 recommended a dividend Rs. 4/- (200% ) per equity share of face value of Rs. 2/- for the financial year ended March 31, 2026. subject to approval of the shareholders at the ensuing AGM. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, September 04, 2026, as the ‘Record Date’ for determining entitlement of Members to dividend for the financial year ended March 31, 2026. The dividend, if approved by the Members at the AGM, shall be paid within 30 days from the date of its declaration, subject to deduction of applicable taxes at source. The AGM Notice and Annual Report will be filed separately. We request you to take the above on record. Thanking you, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance officer